retatrutide type 2 diabetes trial 2024 Perceived benefits of treatment for obesity with retatrutide: A qualitative study of patients in a phase clinical Phase 2 trial results demonstrate

Originally developed under the brand name Ozempic for type 2 diabetes, it later received FDA approval as Wegovy at a higher dose specifically for chronic weight management

If you purchase something mentioned in this article, we may earn a small commission

Additional safety considerations include risk of dehydration and acute kidney injury, potential worsening of diabetic retinopathy with rapid glucose improvement (particularly with semaglutide), and hypoglycemia risk when combined with insulin or sulfonylureas

Metabolic syndrome models investigated in research models of metabolic dysregulation including central adiposity and insulin sensitivity